美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VIVUS Inc

0.4665

0.0000

成交量：- -

成交額：- -

市值：833.53萬

市盈率：-0.17

高：0.4665

開：0.4665

低：0.4665

收：0.4665

52周最高：4.75

52周最低：0.4369

股本：1,786.77萬

流通股本：1,482.35萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.7026

每股收益(LYR):-2.9605

淨資產收益率：47.47%

總資產收益率：-2.20%

市淨率：-0.11

市盈率(LYR):-0.16

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

VIVUS Inc

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.vivus.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Vivus, Inc.是一家生物製藥公司，美國FDA批准兩種治療：Qsymia慢性體重管理和STENDRA勃起功能障礙。 STENDRA也被批准由歐洲委員會，或EC，商品名，SPEDRA，勃起功能障礙在歐盟的治療。 Qsymia（芬特明和托吡酯緩釋）2012年7月被美國FDA批准，作為輔助低熱量飲食和增加了慢性體重管理的成人患者體力活動與30或初始體重指數（BMI）更大（肥胖），或27或更大（超重）中的至少一個與體重相關的合併症，如高血壓，2型糖尿病或高膽固醇（血脂異常）的存在。 Qsymia採用了專利配方，從兩個以前批準的藥品，芬特明和托吡酯結合低劑量的活性成分。雖然動作的確切機制是未知的，Qsymia被認為抑制食慾和增加飽腹感，或充滿的感覺，這種影響飲食行為的兩個主要機制。在2012年9月，通過Qsymia認證送貨上門的網絡數量有限成為美國市場上。 2013年7月，Qsymia通過約8000沃爾格林，Costco公司成為零售藥店提供杜安里德藥店nationwide.公司在美國加州於1991年成立並且於1996年重新合併在特拉華州。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/VVUS/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VVUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","market":"US","secType":"STK","nameCN":"VIVUS Inc","latestPrice":0.4665,"timestamp":1594929600000,"preClose":0.4665,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":14823450,"shares":17867697,"eps":-2.702649,"marketStatus":"退市","change":0,"latestTime":"03-18 12:15:31 EDT","open":0.4665,"high":0.4665,"low":0.4665,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.702649,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773864000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":765604800000,"exchange":"NASDAQ","adjPreClose":0.4665,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","floatShares":14823450,"roa":"-2.20%","roe":"47.47%","lyrEps":-2.96053,"shares":17867697,"dividePrice":0,"high":0.4665,"amplitude":0,"preClose":0.4665,"low":0.4665,"week52Low":0.4369,"pbRate":"-0.11","week52High":4.75,"institutionHeld":0.1227,"latestPrice":0.4665,"eps":-2.702649,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.702649,"open":0.4665},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VVUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-06","symbol":"VVUS","fiscalQuarterEnding":"2020/03","expectedEps":-0.8,"name":null,"time":"盤後","type":"earning","dateTimestamp":1588737600000,"reportTimeType":"post","actualEps":-0.49},{"date":"2020-03-03","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-0.59,"defaultRemindTime":1583269200000,"name":null,"time":"盤後","dateTimestamp":1583211600000,"actualEps":null},{"date":"2019-11-05","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.62,"defaultRemindTime":1572987600000,"name":null,"time":"盤後","dateTimestamp":1572930000000,"actualEps":null},{"date":"2019-08-06","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-1,"defaultRemindTime":1565121600000,"name":null,"time":"盤後","dateTimestamp":1565064000000,"actualEps":-1.2},{"market":"US","date":"2019-04-30","symbol":"VVUS","fiscalQuarterEnding":"2019/03","expectedEps":-1.17,"name":null,"time":"盤後","type":"earning","dateTimestamp":1556596800000,"reportTimeType":"post","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VVUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VVUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VVUS","date":"2020-07-15","current":-0.172608,"percent":0.938697,"low":-1.245839,"twenty":-0.999217,"median":-0.717023,"eighty":-0.611569,"high":-0.284472,"avg":-0.763673,"sd":0.220207,"marketCap":10838545},"quantilePoints":[],"updateTime":1773850531573},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.vivus.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Vivus, Inc.是一家生物製藥公司，美國FDA批准兩種治療：Qsymia慢性體重管理和STENDRA勃起功能障礙。 STENDRA也被批准由歐洲委員會，或EC，商品名，SPEDRA，勃起功能障礙在歐盟的治療。 Qsymia（芬特明和托吡酯緩釋）2012年7月被美國FDA批准，作為輔助低熱量飲食和增加了慢性體重管理的成人患者體力活動與30或初始體重指數（BMI）更大（肥胖），或27或更大（超重）中的至少一個與體重相關的合併症，如高血壓，2型糖尿病或高膽固醇（血脂異常）的存在。 Qsymia採用了專利配方，從兩個以前批準的藥品，芬特明和托吡酯結合低劑量的活性成分。雖然動作的確切機制是未知的，Qsymia被認為抑制食慾和增加飽腹感，或充滿的感覺，這種影響飲食行為的兩個主要機制。在2012年9月，通過Qsymia認證送貨上門的網絡數量有限成為美國市場上。 2013年7月，Qsymia通過約8000沃爾格林，Costco公司成為零售藥店提供杜安里德藥店nationwide.公司在美國加州於1991年成立並且於1996年重新合併在特拉華州。","exchange":"NASDAQ","name":"VIVUS Inc","nameEN":"VIVUS Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":null}}